S&P 500   4,227.56 (+0.48%)
DOW   33,427.97 (+0.27%)
QQQ   326.68 (+0.80%)
AAPL   170.26 (+1.05%)
MSFT   288.17 (+0.40%)
META   179.94 (+1.38%)
GOOGL   119.97 (+0.95%)
AMZN   140.81 (+0.12%)
TSLA   864.74 (+0.56%)
NVDA   184.54 (+2.85%)
NIO   20.55 (-1.30%)
BABA   92.72 (-2.27%)
AMD   101.08 (+3.02%)
MU   63.89 (+2.52%)
T   18.14 (+0.55%)
CGC   3.21 (+1.90%)
GE   78.81 (-0.11%)
F   15.93 (+0.63%)
DIS   120.72 (+2.57%)
AMC   25.39 (-0.27%)
PYPL   101.14 (+2.05%)
PFE   49.19 (+1.86%)
NFLX   246.08 (+1.39%)
S&P 500   4,227.56 (+0.48%)
DOW   33,427.97 (+0.27%)
QQQ   326.68 (+0.80%)
AAPL   170.26 (+1.05%)
MSFT   288.17 (+0.40%)
META   179.94 (+1.38%)
GOOGL   119.97 (+0.95%)
AMZN   140.81 (+0.12%)
TSLA   864.74 (+0.56%)
NVDA   184.54 (+2.85%)
NIO   20.55 (-1.30%)
BABA   92.72 (-2.27%)
AMD   101.08 (+3.02%)
MU   63.89 (+2.52%)
T   18.14 (+0.55%)
CGC   3.21 (+1.90%)
GE   78.81 (-0.11%)
F   15.93 (+0.63%)
DIS   120.72 (+2.57%)
AMC   25.39 (-0.27%)
PYPL   101.14 (+2.05%)
PFE   49.19 (+1.86%)
NFLX   246.08 (+1.39%)
S&P 500   4,227.56 (+0.48%)
DOW   33,427.97 (+0.27%)
QQQ   326.68 (+0.80%)
AAPL   170.26 (+1.05%)
MSFT   288.17 (+0.40%)
META   179.94 (+1.38%)
GOOGL   119.97 (+0.95%)
AMZN   140.81 (+0.12%)
TSLA   864.74 (+0.56%)
NVDA   184.54 (+2.85%)
NIO   20.55 (-1.30%)
BABA   92.72 (-2.27%)
AMD   101.08 (+3.02%)
MU   63.89 (+2.52%)
T   18.14 (+0.55%)
CGC   3.21 (+1.90%)
GE   78.81 (-0.11%)
F   15.93 (+0.63%)
DIS   120.72 (+2.57%)
AMC   25.39 (-0.27%)
PYPL   101.14 (+2.05%)
PFE   49.19 (+1.86%)
NFLX   246.08 (+1.39%)
S&P 500   4,227.56 (+0.48%)
DOW   33,427.97 (+0.27%)
QQQ   326.68 (+0.80%)
AAPL   170.26 (+1.05%)
MSFT   288.17 (+0.40%)
META   179.94 (+1.38%)
GOOGL   119.97 (+0.95%)
AMZN   140.81 (+0.12%)
TSLA   864.74 (+0.56%)
NVDA   184.54 (+2.85%)
NIO   20.55 (-1.30%)
BABA   92.72 (-2.27%)
AMD   101.08 (+3.02%)
MU   63.89 (+2.52%)
T   18.14 (+0.55%)
CGC   3.21 (+1.90%)
GE   78.81 (-0.11%)
F   15.93 (+0.63%)
DIS   120.72 (+2.57%)
AMC   25.39 (-0.27%)
PYPL   101.14 (+2.05%)
PFE   49.19 (+1.86%)
NFLX   246.08 (+1.39%)
NASDAQ:RWLK

ReWalk Robotics - RWLK Stock Forecast, Price & News

$1.08
+0.02 (+1.89%)
(As of 08/12/2022 10:15 AM ET)
Add
Compare
Today's Range
$1.08
$1.10
50-Day Range
$0.87
$1.06
52-Week Range
$0.81
$2.78
Volume
650 shs
Average Volume
173,353 shs
Market Capitalization
$67.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.50

ReWalk Robotics MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
131.5% Upside
$2.50 Price Target
Short Interest
Bearish
2.97% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.38mentions of ReWalk Robotics in the last 14 days
Based on 10 Articles This Week
Insider Trading
Acquiring Shares
$290,673 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.20) to ($0.15) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.95 out of 5 stars

Medical Sector

786th out of 1,112 stocks

Surgical Appliances & Supplies Industry

17th out of 23 stocks

RWLK stock logo

About ReWalk Robotics (NASDAQ:RWLK) Stock

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.

Analyst Ratings Changes

Several research analysts recently commented on RWLK shares. HC Wainwright reduced their price target on ReWalk Robotics from $3.50 to $2.50 and set a "buy" rating for the company in a research report on Wednesday. StockNews.com started coverage on ReWalk Robotics in a research report on Saturday, August 6th. They set a "sell" rating for the company.

ReWalk Robotics Stock Up 2.9 %

RWLK opened at $1.06 on Friday. ReWalk Robotics has a 12-month low of $0.81 and a 12-month high of $2.78. The stock has a market cap of $66.33 million, a price-to-earnings ratio of -4.08 and a beta of 2.55. The business has a 50 day moving average of $0.99 and a 200-day moving average of $1.04.

ReWalk Robotics (NASDAQ:RWLK - Get Rating) last released its quarterly earnings data on Friday, May 13th. The medical device company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.05) by ($0.02). ReWalk Robotics had a negative net margin of 270.83% and a negative return on equity of 17.19%. The business had revenue of $0.88 million during the quarter, compared to analyst estimates of $2.20 million. During the same period in the previous year, the business earned ($0.08) earnings per share. As a group, analysts expect that ReWalk Robotics will post -0.2 earnings per share for the current year.

Insider Transactions at ReWalk Robotics

In other news, major shareholder Global Fund Lp Lind II bought 236,616 shares of the stock in a transaction dated Thursday, June 2nd. The shares were bought at an average price of $1.00 per share, for a total transaction of $236,616.00. Following the completion of the purchase, the insider now owns 4,092,022 shares in the company, valued at $4,092,022. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Over the last quarter, insiders have bought 284,794 shares of company stock worth $285,080. Company insiders own 0.78% of the company's stock.

Receive RWLK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ReWalk Robotics and its competitors with MarketBeat's FREE daily newsletter.

RWLK Stock News Headlines

ReWalk Robotics (RWLK) Scheduled to Post Earnings on Tuesday
100th ReWalk Exoskeleton Supplied in Germany
ReWalk Robotics Announces Share Repurchase Program
See More Headlines
Receive RWLK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ReWalk Robotics and its competitors with MarketBeat's FREE daily newsletter.

RWLK Company Calendar

Last Earnings
11/11/2021
Today
8/12/2022
Next Earnings (Estimated)
11/09/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:RWLK
Fax
N/A
Employees
51
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$2.50
High Stock Price Forecast
$2.50
Low Stock Price Forecast
$2.50
Forecasted Upside/Downside
+131.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-12,740,000.00
Net Margins
-270.83%
Pretax Margin
-268.99%

Debt

Sales & Book Value

Annual Sales
$5.97 million
Book Value
$1.29 per share

Miscellaneous

Free Float
62,089,000
Market Cap
$67.59 million
Optionable
Not Optionable
Beta
2.55

Key Executives

  • Mr. Lawrence J. Jasinski BS (Age 65)
    MBA, CEO & Director
    Comp: $648.52k
  • Ms. Miri Pariente (Age 45)
    VP of Operations, Regulatory & Quality
    Comp: $321.75k
  • Ms. Jeannine Lynch (Age 57)
    VP of Market Access & Strategy
    Comp: $422.25k
  • Mr. David Hexner
    VP of R&D
  • Mr. Almog Adar (Age 38)
    Director of Fin. & Corp. Financial Controller
  • Ms. Kathleen O'Donnell
    VP of Marketing & New Bus. Devel.
  • Ms. Judy Kula
    VP of Customer Service, HR & Bus. Affairs
  • Mr. Ami Kraft (Age 79)
    Exec. Advisor to the CEO













RWLK Stock - Frequently Asked Questions

Should I buy or sell ReWalk Robotics stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ReWalk Robotics in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" RWLK shares.
View RWLK analyst ratings
or view top-rated stocks.

What is ReWalk Robotics' stock price forecast for 2022?

1 Wall Street research analysts have issued 12 month price objectives for ReWalk Robotics' stock. Their RWLK share price forecasts range from $2.50 to $2.50. On average, they expect the company's stock price to reach $2.50 in the next twelve months. This suggests a possible upside of 135.8% from the stock's current price.
View analysts price targets for RWLK
or view top-rated stocks among Wall Street analysts.

How have RWLK shares performed in 2022?

ReWalk Robotics' stock was trading at $1.23 at the beginning of the year. Since then, RWLK shares have decreased by 13.8% and is now trading at $1.06.
View the best growth stocks for 2022 here
.

When is ReWalk Robotics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 9th 2022.
View our RWLK earnings forecast
.

How were ReWalk Robotics' earnings last quarter?

ReWalk Robotics Ltd. (NASDAQ:RWLK) issued its quarterly earnings results on Thursday, November, 11th. The medical device company reported ($0.06) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.06). The medical device company had revenue of $1.97 million for the quarter, compared to analyst estimates of $1.60 million. ReWalk Robotics had a negative net margin of 270.83% and a negative trailing twelve-month return on equity of 17.19%. During the same period last year, the business earned ($0.18) earnings per share.

What other stocks do shareholders of ReWalk Robotics own?

What is ReWalk Robotics' stock symbol?

ReWalk Robotics trades on the NASDAQ under the ticker symbol "RWLK."

Who are ReWalk Robotics' major shareholders?

ReWalk Robotics' stock is owned by many different retail and institutional investors. Top institutional shareholders include Group One Trading L.P. (0.00%). Insiders that own company stock include Global Fund Lp Lind II, Jeff Dykan and Lawrence J Jasinski.
View institutional ownership trends
.

How do I buy shares of ReWalk Robotics?

Shares of RWLK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ReWalk Robotics' stock price today?

One share of RWLK stock can currently be purchased for approximately $1.06.

How much money does ReWalk Robotics make?

ReWalk Robotics (NASDAQ:RWLK) has a market capitalization of $66.33 million and generates $5.97 million in revenue each year. The medical device company earns $-12,740,000.00 in net income (profit) each year or ($0.26) on an earnings per share basis.

How can I contact ReWalk Robotics?

ReWalk Robotics' mailing address is 3 Hatnufa Street Floor 6, Yokneam Ilit L3, 2069203. The official website for the company is www.rewalk.com. The medical device company can be reached via phone at (724) 959-0123 or via email at ir@rewalk.com.

This page (NASDAQ:RWLK) was last updated on 8/12/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.